Jack Bergman - Publications

Affiliations: 
McLean Hospital, Harvard Medical School, Belmont, MA, United States 

126 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hasbi A, Madras BK, Bergman J, Kohut S, Lin Z, Withey SL, George SR. Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794. PMID 31972514 DOI: 10.1016/j.isci.2019.100794  0.84
2019 Withey SL, Doyle RJ, Porter EN, Bergman J, Kangas BD. Discrimination learning in oxycodone-treated nonhuman primates. Drug and Alcohol Dependence. 207: 107778. PMID 31816487 DOI: 10.1016/j.drugalcdep.2019.107778  0.84
2019 Kangas BD, Zakarian AS, Vemuri K, Alapafuja SO, Jiang S, Nikas SP, Makriyannis A, Bergman J. Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 31641018 DOI: 10.1124/jpet.119.261818  0.56
2019 de Moura FB, Withey SL, Bergman J. Enhancement of opioid antinociception by nicotine. The Journal of Pharmacology and Experimental Therapeutics. PMID 31527281 DOI: 10.1124/jpet.119.261438  1
2019 Withey SL, Spealman RD, Bergman J, Paronis CA. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. The Journal of Pharmacology and Experimental Therapeutics. PMID 31413139 DOI: 10.1124/jpet.119.259010  0.84
2019 de Moura FB, Kohut SJ, Bergman J. Medications development for food-based and drug use disorders. Advances in Pharmacology (San Diego, Calif.). 86: 197-236. PMID 31378252 DOI: 10.1016/bs.apha.2019.04.005  1
2019 Kangas BD, Doyle RJ, Kohut SJ, Bergman J, Kaufman MJ. Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates. Psychopharmacology. PMID 30877326 DOI: 10.1007/s00213-019-05211-5  1
2018 Kohut SJ, Bergman J. Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys. European Journal of Pharmacology. PMID 30268662 DOI: 10.1016/j.ejphar.2018.09.025  1
2018 de Moura FB, Kohut SJ, Bergman J. Limited modulation of the abuse-related behavioral effects of d-methamphetamine by disulfiram. Experimental and Clinical Psychopharmacology. PMID 29963872 DOI: 10.1037/pha0000222  1
2018 Withey SL, Doyle MR, Bergman J, Desai RI. Involvement of Nicotinic Receptor Subtypes in Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 29784663 DOI: 10.1124/jpet.118.248070  0.84
2018 Withey SL, Paronis CA, Bergman J. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. The Journal of Pain : Official Journal of the American Pain Society. PMID 29477761 DOI: 10.1016/j.jpain.2018.02.003  0.84
2018 Fischer KD, Houston ACW, Desai RI, Doyle MR, Bergman J, Mian M, Mannix R, Sulzer DL, Choi SJ, Mosharov EV, Hodgson NW, Bechtholt A, Miczek KA, Rosenberg PA. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology. PMID 29468294 DOI: 10.1007/s00213-018-4848-1  0.64
2018 Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Long-lasting in vivo effects of the cannabinoid CB1 antagonist AM6538. The Journal of Pharmacology and Experimental Therapeutics. PMID 29311110 DOI: 10.1124/jpet.117.245647  0.84
2017 Puhl MD, Desai RI, Takagi S, Presti KT, Doyle MR, Donahue RJ, Landino SM, Bergman J, Carlezon WA, Coyle JT. N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse. Addiction Biology. PMID 29168271 DOI: 10.1111/adb.12577  0.64
2017 Kangas BD, Bergman J. Touchscreen technology in the study of cognition-related behavior. Behavioural Pharmacology. PMID 29064843 DOI: 10.1097/FBP.0000000000000356  0.56
2017 Jacobs DS, Barkin CE, Kohut MR, Bergman J, Kohut SJ. Effects of lorcaserin (Belviq(®)) on nicotine- and food-maintained responding in non-human primates. Drug and Alcohol Dependence. 181: 94-101. PMID 29040827 DOI: 10.1016/j.drugalcdep.2017.09.008  1
2017 Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. The Journal of Pharmacology and Experimental Therapeutics. PMID 28947487 DOI: 10.1124/jpet.117.244392  0.56
2017 Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology. PMID 28889212 DOI: 10.1007/s00213-017-4731-5  1
2016 Jacobs DS, Kohut SJ, Jiang S, Nikas SP, Makriyannis A, Bergman J. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance. Experimental and Clinical Psychopharmacology. 24: 320-330. PMID 27690502 DOI: 10.1037/pha0000081  1
2016 Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A. Novel C-Ring-Hydroxy-substituted Controlled Deactivation Cannabinergic Analogues. Journal of Medicinal Chemistry. PMID 27367336 DOI: 10.1021/acs.jmedchem.6b00717  0.84
2016 Kohut SJ, Bergman J. Reinforcing effectiveness of nicotine in nonhuman primates: effects of nicotine dose and history of nicotine self-administration. Psychopharmacology. PMID 27076210 DOI: 10.1007/s00213-016-4293-y  1
2016 Desai RI, Sullivan KA, Kohut SJ, Bergman J. Influence of experimental history on nicotine self-administration in squirrel monkeys. Psychopharmacology. PMID 27040402 DOI: 10.1007/s00213-016-4274-1  1
2016 Desai RI, Doyle MR, Withey SL, Bergman J. Nicotinic effects of tobacco smoke constituents in nonhuman primates. Psychopharmacology. PMID 26892379 DOI: 10.1007/s00213-016-4238-5  0.84
2016 Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26888056 DOI: 10.1038/npp.2016.27  1
2016 Kangas BD, Bergman J, Coyle JT. Touchscreen assays of learning, response inhibition, and motivation in the marmoset (Callithrix jacchus). Animal Cognition. PMID 26846231 DOI: 10.1007/s10071-016-0959-4  0.56
2016 Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J. Comparisons of Δ9-tetrahydrocannabinol and Anandamide on a Battery of Cognition-related Behavior in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 26826191 DOI: 10.1124/jpet.115.228189  1
2016 Desai RI, Bergman J. Nicotine-Targeting Nano-Vaccines for Smoking Cessation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 377-8. PMID 26657956 DOI: 10.1038/npp.2015.234  0.64
2015 Kohut SJ, Bergman J, Blough BE. Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys. Psychopharmacology. PMID 26713332 DOI: 10.1007/s00213-015-4186-5  1
2015 Kangas BD, Bergman J. Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates. Psychopharmacology. PMID 26490034 DOI: 10.1007/s00213-015-4107-7  0.56
2015 Willner P, Bergman J, Vanderschuren L, Ellenbroek B. Pharmacological approaches to the study of social behaviour. Behavioural Pharmacology. 26: 501-4. PMID 26221829 DOI: 10.1097/FBP.0000000000000180  1
2015 Desai RI, Bergman J. Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2207-16. PMID 25742871 DOI: 10.1038/npp.2015.64  1
2015 Willner P, Bergman J, Vanderschuren L, Ellenbroek B. The behavioural pharmacology of the basal ganglia: in memory of Lex Cools. Behavioural Pharmacology. 26: 1-2. PMID 25539481 DOI: 10.1097/FBP.0000000000000125  1
2015 Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, et al. Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. Journal of Medicinal Chemistry. 58: 665-81. PMID 25470070 DOI: 10.1021/jm501165d  1
2015 Bergman J, Rheingold CG. Dopamine D4 receptor antagonists for the treatment of cocaine use disorders Cns and Neurological Disorders - Drug Targets. 14: 707-715.  1
2014 Willner P, Bergman J, Vanderschuren L, Ellenbroek B. The behavioural pharmacology of stress. Behavioural Pharmacology. 25: 337-9. PMID 25083566 DOI: 10.1097/FBP.0000000000000082  1
2014 Kangas BD, Bergman J. Operant nociception in nonhuman primates. Pain. 155: 1821-8. PMID 24968803 DOI: 10.1016/j.pain.2014.06.010  1
2014 Desai RI, Bergman J. Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. The Journal of Pharmacology and Experimental Therapeutics. 348: 478-88. PMID 24389640 DOI: 10.1124/jpet.113.211235  1
2014 Kangas BD, Bergman J. Repeated acquisition and discrimination reversal in the squirrel monkey (Saimiri sciureus). Animal Cognition. 17: 221-8. PMID 23794073 DOI: 10.1007/s10071-013-0654-7  1
2013 Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Controlled-deactivation cannabinergic ligands. Journal of Medicinal Chemistry. 56: 10142-57. PMID 24286207 DOI: 10.1021/jm4016075  1
2013 Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nature Neuroscience. 16: 1652-61. PMID 24121737 DOI: 10.1038/nn.3540  1
2013 Bergman J, Willner P, Vanderschuren L. Current approaches to the laboratory assessment of abuse potential. Behavioural Pharmacology. 24: 337-9. PMID 23903241 DOI: 10.1097/FBP.0b013e3283650d92  1
2013 Kangas BD, Delatte MS, Vemuri VK, Thakur GA, Nikas SP, Subramanian KV, Shukla VG, Makriyannis A, Bergman J. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists. The Journal of Pharmacology and Experimental Therapeutics. 344: 561-7. PMID 23287700 DOI: 10.1124/jpet.112.201962  1
2013 Desai RI, Thakur GA, Vemuri VK, Bajaj S, Makriyannis A, Bergman J. Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs. The Journal of Pharmacology and Experimental Therapeutics. 344: 319-28. PMID 23197773 DOI: 10.1124/jpet.112.198374  1
2013 Mello NK, Fivel PA, Kohut SJ, Bergman J. Effects of chronic buspirone treatment on cocaine self-administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 455-67. PMID 23072835 DOI: 10.1038/npp.2012.202  1
2013 Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J. Diuretic effects of cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 344: 8-14. PMID 23019138 DOI: 10.1124/jpet.112.199331  1
2013 Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, Skolnick P. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 445-58. PMID 22827916 DOI: 10.1017/S1461145712000661  1
2013 Schindler CW, Justinova Z, Lafleur D, Woods D, Roschke V, Hallak H, Sklair-Tavron L, Redhi GH, Yasar S, Bergman J, Goldberg SR. Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys. Addiction Biology. 18: 30-9. PMID 22264200 DOI: 10.1111/j.1369-1600.2011.00424.x  1
2013 Katz JL, Bergman J. Obituary: Peter B. Dews (1922-2012) Psychopharmacology. 1-2. DOI: 10.1007/s00213-013-3055-3  1
2012 Willner P, Bergman J, Vanderschuren L. Pharmacological approaches to feeding behaviour and eating disorders. Behavioural Pharmacology. 23: 439-40. PMID 22854303 DOI: 10.1097/FBP.0b013e328358389f  1
2012 Kangas BD, Bergman J. A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys. Journal of Neuroscience Methods. 209: 331-6. PMID 22790109 DOI: 10.1016/j.jneumeth.2012.06.028  1
2012 Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochemical Pharmacology. 84: 882-90. PMID 22781742 DOI: 10.1016/j.bcp.2012.06.023  1
2011 Willner P, Bergman J, Vanderschuren L. Stimulus properties of drugs and the behavioural pharmacology of pain: in memory of Francis Colpaert. Behavioural Pharmacology. 22: 379-81. PMID 21836458 DOI: 10.1097/FBP.0b013e32834a66b0  1
2011 Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 336: 488-95. PMID 21051498 DOI: 10.1124/jpet.110.173823  1
2010 Desai RI, Bergman J. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. The Journal of Pharmacology and Experimental Therapeutics. 335: 807-16. PMID 20847037 DOI: 10.1124/jpet.110.173773  1
2010 Willner P, Bergman J, Vanderschuren L. Non-traditional drug targets in behavioural pharmacology. Behavioural Pharmacology. 21: 375-7. PMID 20716969 DOI: 10.1097/FBP.0b013e32833e7923  1
2010 Desai RI, Paronis CA, Martin J, Desai R, Bergman J. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. The Journal of Pharmacology and Experimental Therapeutics. 333: 834-43. PMID 20190012 DOI: 10.1124/jpet.110.165746  1
2009 Willner P, Bergman J, Sanger D. Behavioural pharmacology of impulse control. Behavioural Pharmacology. 20: 558-60. PMID 19741302 DOI: 10.1097/01.fbp.0000359407.60839.2d  1
2008 Bergman J. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Experimental and Clinical Psychopharmacology. 16: 475-83. PMID 19086768 DOI: 10.1037/a0014398  1
2008 Willner P, Bergman J, Sanger D. Behavioural genetics and its relevance to psychiatry. Behavioural Pharmacology. 19: 371-3. PMID 18690098 DOI: 10.1097/FBP.0b013e328310ac30  1
2008 Barrett JE, Bergman J. Peter B. Dews and pharmacological studies on behavior. The Journal of Pharmacology and Experimental Therapeutics. 326: 683-90. PMID 18544675 DOI: 10.1124/jpet.108.139261  1
2008 Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93: 666-70. PMID 18076956 DOI: 10.1016/j.physbeh.2007.11.007  1
2008 Rocha BA, Bergman J, Comer SD, Haney M, Spealman RD. Development of medications for heroin and cocaine addiction and regulatory aspects of abuse liability testing Animal and Translational Models For Cns Drug Discovery. 3: 221-270. DOI: 10.1016/B978-0-12-373861-5.00027-8  1
2007 Desai RI, Neumeyer JL, Bergman J, Paronis CA. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behavioural Pharmacology. 18: 745-54. PMID 17989512 DOI: 10.1097/FBP.0b013e3282f14ee6  1
2007 Schindler CW, Graczyk Z, Gilman JP, Negus SS, Bergman J, Mello NK, Goldberg SR. Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. European Journal of Pharmacology. 576: 107-13. PMID 17707792 DOI: 10.1016/j.ejphar.2007.07.053  1
2007 Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. European Journal of Pharmacology. 558: 98-106. PMID 17207791 DOI: 10.1016/j.ejphar.2006.11.042  1
2007 Willner P, Sanger D, Bergman J. Editorial: The behavioural pharmacology of the hippocampus Behavioural Pharmacology. 18: 321-323. DOI: 10.1097/FBP.0b013e3282f00e88  1
2006 Bergman J, Paronis CA. Measuring the reinforcing strength of abused drugs. Molecular Interventions. 6: 273-83. PMID 17035668 DOI: 10.1124/mi.6.5.9  1
2006 Willner P, Sanger D, Bergman J. Editorial - Behavioural aspects of neurodegeneration and neuroprotection Behavioural Pharmacology. 17: 375-376. DOI: 10.1097/00008877-200609000-00001  1
2005 Yasar S, Gaal J, Justinova Z, Bergman J. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys. Psychopharmacology. 182: 95-103. PMID 15990999 DOI: 10.1007/s00213-005-0063-y  1
2005 Gasior M, Bergman J, Kallman MJ, Paronis CA. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 758-64. PMID 15526000 DOI: 10.1038/sj.npp.1300593  1
2005 Bergman J, Willner P, Sanger D. Editorial - Behavioural pharmacology of cannabinoids Behavioural Pharmacology. 16: 271-274. DOI: 10.1097/00008877-200509000-00001  1
2004 Jutkiewicz EM, Bergman J. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions. The Journal of Pharmacology and Experimental Therapeutics. 311: 1008-15. PMID 15292458 DOI: 10.1124/jpet.104.071092  1
2004 Czoty PW, Ramanathan CR, Mutschler NH, Makriyannis A, Bergman J. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. The Journal of Pharmacology and Experimental Therapeutics. 311: 720-7. PMID 15240827 DOI: 10.1124/jpet.104.071035  1
2004 Czoty PW, Makriyannis A, Bergman J. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology. 175: 170-8. PMID 15064912 DOI: 10.1007/s00213-004-1798-6  1
2004 Gasior M, Paronis CA, Bergman J. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 308: 249-59. PMID 14563783 DOI: 10.1124/jpet.103.052795  1
2004 Wilner P, Sanger D, Bergman J. Neurobehavioural plasticity Behavioural Pharmacology. 15: 311-312.  1
2003 Sanger D, Willner P, Bergman J. Applications of behavioural pharmacology in drug discovery. Behavioural Pharmacology. 14: 363-7. PMID 14501250 DOI: 10.1097/01.fbp.0000092534.95921.34  1
2003 Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. European Journal of Pharmacology. 474: 137-40. PMID 12921854 DOI: 10.1016/S0014-2999(03)02008-9  1
2003 Yasar S, Bergman J, Munzar P, Redhi G, Tober C, Knebel N, Zschiesche M, Paronis C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. European Journal of Pharmacology. 465: 257-65. PMID 12681437 DOI: 10.1016/S0014-2999(03)01533-4  1
2002 Paronis CA, Gasior M, Bergman J. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology. 163: 283-91. PMID 12373429 DOI: 10.1007/s00213-002-1180-5  1
2002 Bergman J, Katz JL, Miczek KA. The experimental imperative. Psychopharmacology. 163: 249-50. PMID 12373426 DOI: 10.1007/s00213-002-1226-8  1
2002 Dews PB, O'Brien CP, Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 40: 1257-61. PMID 12204389 DOI: 10.1016/S0278-6915(02)00095-9  1
2002 Mutschler NH, Bergman J. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology. 160: 362-70. PMID 11919663 DOI: 10.1007/s00213-001-0976-z  1
2002 Bergman J, Yasar S, Winger G. Psychomotor stimulant effects of β-phenylethylamine in monkeys treated with MAO-B inhibitors Psychopharmacology. 159: 21-30. PMID 11797065 DOI: 10.1007/s002130100890  1
2002 Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 300: 180-7. PMID 11752114 DOI: 10.1124/jpet.300.1.180  1
2001 Paronis CA, Cox ED, Cook JM, Bergman J. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacology. 156: 461-8. PMID 11498724 DOI: 10.1007/s002130100754  1
2001 Carey GJ, Bergman J. Enadoline discrimination in squirrel monkeys: Effects of opioid agonists and antagonists Journal of Pharmacology and Experimental Therapeutics. 297: 215-223. PMID 11259547  1
2000 Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. Psychopharmacology. 153: 67-84. PMID 11255930 DOI: 10.1007/s002130000567  1
2000 Caine SB, Negus SS, Mello NK, Bergman J. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Experimental and Clinical Psychopharmacology. 8: 404-14. PMID 10975632 DOI: 10.1037//1064-1297.8.3.404  1
1999 Caine SB, Negus SS, Mello NK, Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. The Journal of Pharmacology and Experimental Therapeutics. 291: 353-60. PMID 10490924  1
1999 Paronis CA, Bergman J. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys Journal of Pharmacology and Experimental Therapeutics. 290: 1222-1229. PMID 10454498  1
1998 Tidey JW, Bergman J. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. The Journal of Pharmacology and Experimental Therapeutics. 285: 1163-74. PMID 9618419  1
1997 Bruhwyler J, Liégeois JF, Bergman J, Carey G, Goudie A, Taylor A, Meltzer H, Delarge J, Géczy J. JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: A review of its behavioural properties Pharmacological Research. 36: 255-264. PMID 9425613 DOI: 10.1006/phrs.1997.0231  1
1997 Spealman RD, Bergman J, Rosenzweig-Lipson S. Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology. 133: 283-92. PMID 9361335 DOI: 10.1007/s002130050403  1
1997 Carey GJ, Bergman J. Discriminative-stimulus effects of clozapine in squirrel monkeys: Comparison with conventional and novel antipsychotic drugs Psychopharmacology. 132: 261-269. PMID 9292626 DOI: 10.1007/s002130050344  1
1997 Bergman J, Paronis CA. Back to the future. Commentary on Rodgers, 'Animal models of anxiety: Where next?' Behavioural Pharmacology. 8: 502-504.  1
1996 Simons FE, Bergman JN, Watson WT, Simons KJ. The clinical pharmacology of fexofenadine in children. The Journal of Allergy and Clinical Immunology. 98: 1062-4. PMID 8977506 DOI: 10.1016/S0091-6749(96)80192-8  1
1996 Gatch MB, Liguori A, Negus SS, Mello NK, Bergman J, Liguori T. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys. European Journal of Pharmacology. 298: 31-6. PMID 8867916 DOI: 10.1016/0014-2999(95)00769-5  1
1996 Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 276: 942-50. PMID 8786574  1
1996 Grech DM, Spealman RD, Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology. 125: 97-104. PMID 8783382 DOI: 10.1007/BF02249407  1
1996 Liguori A, Morse WH, Bergman J. Respiratory effects of opioid full and partial agonists in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 277: 462-72. PMID 8613955  1
1996 Bergman J. Sense and sensibility. Commentary on Gold's 'Integration of molecular biological techniques and behavioural pharmacology' Behavioural Pharmacology. 7: 621-623.  1
1995 Bergman J, Rosenzweig-Lipson S, Spealman RD. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 273: 40-8. PMID 7714795  1
1994 Bergman J. Preclinical assessment of cocaine antagonist drugs in squirrel monkeys Nida Research Monograph Series. 131-138. PMID 8742811  1
1994 Yasar S, Bergman J. Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies Clinical Pharmacology and Therapeutics. 56: 768-773. PMID 7995019  1
1994 Goldberg SR, Yasar S, Bergman J, Youdim MBH. Introduction: Examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline) Clinical Pharmacology and Therapeutics. 56: 721-724. PMID 7995013  1
1994 Rosenzweig-Lipson S, Bergman J. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys European Journal of Pharmacology. 260: 237-241. PMID 7988649 DOI: 10.1016/0014-2999(94)90343-3  1
1994 Rosenzweig-Lipson S, Hesterberg P, Bergman J. Observational studies of dopamine D1 and D2 agonists in squirrel monkeys Psychopharmacology. 116: 9-18. PMID 7862937 DOI: 10.1007/BF02244865  1
1994 Ator NA, Bergman J, Dworkin SI, Koob GF, Winger G. Behavioral, pharmacologic and neurobiologic variables important to the analysis of drug self-administration: Implications for the discovery of potential pharmacotherapies Nida Research Monograph Series. 99-102.  1
1994 Spealman RD, Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine: Comparison of μ, κ and δ agonists in squirrel monkeys discriminating low doses of cocaine Behavioural Pharmacology. 5: 21-31.  1
1993 Rosenzweig-Lipson S, Bergman J. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys Journal of Pharmacology and Experimental Therapeutics. 265: 1039-1046. PMID 8099614  1
1993 Rosenzweig-Lipson S, Bergman J. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys Journal of Pharmacology and Experimental Therapeutics. 267: 765-775. PMID 7902432  1
1993 Rosenweig-Lipson S, Bergman J. Discriminative stimulus effects of cocaine and the high-efficacy D1 agonist SKF 81297 in squirrel monkeys Nida Research Monograph Series. 253.  1
1993 Bergman J, Hesterberg P, Spealman RD. Modification of the behavioral effects of cocaine by opioids in squirrel monkeys Nida Research Monograph Series. 235.  1
1993 Liguori A, Bergman J, Morse WH. Respiratory effects of mu and mixed-action opioid agonists Nida Research Monograph Series. 366.  1
1992 Rosenzweig-Lipson S, Bergman J, Spealman RD, Madras BK. Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharmacology. 107: 186-94. PMID 1377395 DOI: 10.1007/BF02245136  1
1992 Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF. Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine. Neurochemistry International. 20: 147S-152S. PMID 1365414 DOI: 10.1016/0197-0186(92)90228-J  1
1992 Bergman J, Rosenzweig-Lipson S. Cocaine-antagonist effects of limited-efficacy D1 agonists Nida Research Monograph. 119: 185-189. PMID 1359418  1
1992 Spealman RD, Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. The Journal of Pharmacology and Experimental Therapeutics. 261: 607-15. PMID 1315861  1
1991 Bergman J, Madras BK, Spealman RD. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 258: 910-7. PMID 1890625  1
1991 Spealman RD, Bergman J, Madras BK. Self-administration of the high-affinity cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. Pharmacology, Biochemistry, and Behavior. 39: 1011-3. PMID 1763097 DOI: 10.1016/0091-3057(91)90067-C  1
1991 Spealman RD, Bergman J, Madras BK, Melia KF. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 258: 945-53. PMID 1679852  1
1990 Bergman J. Psychomotor stimulant effects of the stereoisomers of chlorpheniramine Psychopharmacology. 101: 132-134. PMID 1967498 DOI: 10.1007/BF02245804  1
1989 Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. The Journal of Pharmacology and Experimental Therapeutics. 251: 142-9. PMID 2795456  1
1989 Bergman J, Warren PH. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys Journal of Pharmacology and Experimental Therapeutics. 248: 1102-1108. PMID 2539457  1
1989 Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 251: 150-5. PMID 2529365  1
Show low-probability matches.